메뉴 건너뛰기




Volumn 7, Issue 6, 2014, Pages 1940-1955

ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO N2 [1 (5 FLUORO 2 PYRIMIDINYL)ETHYL] N4 (5 METHYL 1H PYRAZOL 3 YL) 2,4 PYRIMIDINEDIAMINE; CRIZOTINIB; FLUOROURACIL; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SCATTER FACTOR RECEPTOR; SELUMETINIB; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ADAM PROTEIN; KRAS PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; ONCOPROTEIN; PROTEIN KINASE INHIBITOR; RAS PROTEIN; STAT3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

EID: 84903441759     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.032     Document Type: Article
Times cited : (88)

References (39)
  • 5
    • 0033583220 scopus 로고    scopus 로고
    • C-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function
    • Biscardi J.S., Maa M.C., Tice D.A., Cox M.E., Leu T.H., Parsons S.J. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J.Biol. Chem. 1999, 274:8335-8343.
    • (1999) J.Biol. Chem. , vol.274 , pp. 8335-8343
    • Biscardi, J.S.1    Maa, M.C.2    Tice, D.A.3    Cox, M.E.4    Leu, T.H.5    Parsons, S.J.6
  • 7
    • 0021118703 scopus 로고
    • Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
    • Chou T.C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 1984, 22:27-55.
    • (1984) Adv. Enzyme Regul. , vol.22 , pp. 27-55
    • Chou, T.C.1    Talalay, P.2
  • 8
    • 0021848596 scopus 로고
    • Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding
    • Clark R., Wong G., Arnheim N., Nitecki D., McCormick F. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding. Proc. Natl. Acad. Sci. USA 1985, 82:5280-5284.
    • (1985) Proc. Natl. Acad. Sci. USA , vol.82 , pp. 5280-5284
    • Clark, R.1    Wong, G.2    Arnheim, N.3    Nitecki, D.4    McCormick, F.5
  • 9
    • 44449151030 scopus 로고    scopus 로고
    • Drug development of MET inhibitors: targeting oncogene addiction and expedience
    • Comoglio P.M., Giordano S., Trusolino L. Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat. Rev. Drug Discov. 2008, 7:504-516.
    • (2008) Nat. Rev. Drug Discov. , vol.7 , pp. 504-516
    • Comoglio, P.M.1    Giordano, S.2    Trusolino, L.3
  • 11
    • 0035799531 scopus 로고    scopus 로고
    • Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
    • Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001, 20:2499-2513.
    • (2001) Oncogene , vol.20 , pp. 2499-2513
    • Garcia, R.1    Bowman, T.L.2    Niu, G.3    Yu, H.4    Minton, S.5    Muro-Cacho, C.A.6    Cox, C.E.7    Falcone, R.8    Fairclough, R.9    Parsons, S.10
  • 13
    • 26844556553 scopus 로고    scopus 로고
    • GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways
    • Hart S., Fischer O.M., Prenzel N., Zwick-Wallasch E., Schneider M., Hennighausen L., Ullrich A. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways. Biol. Chem. 2005, 386:845-855.
    • (2005) Biol. Chem. , vol.386 , pp. 845-855
    • Hart, S.1    Fischer, O.M.2    Prenzel, N.3    Zwick-Wallasch, E.4    Schneider, M.5    Hennighausen, L.6    Ullrich, A.7
  • 15
    • 40949135397 scopus 로고    scopus 로고
    • PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
    • Jhawer M., Goel S., Wilson A.J., Montagna C., Ling Y.H., Byun D.S., Nasser S., Arango D., Shin J., Klampfer L., et al. PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. Cancer Res. 2008, 68:1953-1961.
    • (2008) Cancer Res. , vol.68 , pp. 1953-1961
    • Jhawer, M.1    Goel, S.2    Wilson, A.J.3    Montagna, C.4    Ling, Y.H.5    Byun, D.S.6    Nasser, S.7    Arango, D.8    Shin, J.9    Klampfer, L.10
  • 16
    • 3142619403 scopus 로고    scopus 로고
    • The Sema domain of Met is necessary for receptor dimerization and activation
    • Kong-Beltran M., Stamos J., Wickramasinghe D. The Sema domain of Met is necessary for receptor dimerization and activation. Cancer Cell 2004, 6:75-84.
    • (2004) Cancer Cell , vol.6 , pp. 75-84
    • Kong-Beltran, M.1    Stamos, J.2    Wickramasinghe, D.3
  • 18
    • 79952654912 scopus 로고    scopus 로고
    • TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells
    • Lemjabbar-Alaoui H., Sidhu S.S., Mengistab A., Gallup M., Basbaum C. TACE/ADAM-17 phosphorylation by PKC-epsilon mediates premalignant changes in tobacco smoke-exposed lung cells. PLoS ONE 2011, 6:e17489.
    • (2011) PLoS ONE , vol.6
    • Lemjabbar-Alaoui, H.1    Sidhu, S.S.2    Mengistab, A.3    Gallup, M.4    Basbaum, C.5
  • 21
    • 79959337678 scopus 로고    scopus 로고
    • Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
    • MRC COIN Trial Investigators.
    • Maughan T.S., Adams R.A., Smith C.G., Meade A.M., Seymour M.T., Wilson R.H., Idziaszczyk S., Harris R., Fisher D., Kenny S.L., et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet 2011, 377:2103-2114. MRC COIN Trial Investigators.
    • (2011) Lancet , vol.377 , pp. 2103-2114
    • Maughan, T.S.1    Adams, R.A.2    Smith, C.G.3    Meade, A.M.4    Seymour, M.T.5    Wilson, R.H.6    Idziaszczyk, S.7    Harris, R.8    Fisher, D.9    Kenny, S.L.10
  • 24
    • 0037112367 scopus 로고    scopus 로고
    • Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells
    • Mora L.B., Buettner R., Seigne J., Diaz J., Ahmad N., Garcia R., Bowman T., Falcone R., Fairclough R., Cantor A., et al. Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. Cancer Res. 2002, 62:6659-6666.
    • (2002) Cancer Res. , vol.62 , pp. 6659-6666
    • Mora, L.B.1    Buettner, R.2    Seigne, J.3    Diaz, J.4    Ahmad, N.5    Garcia, R.6    Bowman, T.7    Falcone, R.8    Fairclough, R.9    Cantor, A.10
  • 26
    • 56749133149 scopus 로고    scopus 로고
    • The ADAMs: signalling scissors in the tumour microenvironment
    • Murphy G. The ADAMs: signalling scissors in the tumour microenvironment. Nat. Rev. Cancer 2008, 8:929-941.
    • (2008) Nat. Rev. Cancer , vol.8 , pp. 929-941
    • Murphy, G.1
  • 30
    • 0037224740 scopus 로고    scopus 로고
    • The ADAMs family of metalloproteases: multidomain proteins with multiple functions
    • Seals D.F., Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003, 17:7-30.
    • (2003) Genes Dev. , vol.17 , pp. 7-30
    • Seals, D.F.1    Courtneidge, S.A.2
  • 31
    • 79551709762 scopus 로고    scopus 로고
    • Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer
    • Sen B., Peng S., Saigal B., Williams M.D., Johnson F.M. Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer. Clin. Cancer Res. 2011, 17:514-524.
    • (2011) Clin. Cancer Res. , vol.17 , pp. 514-524
    • Sen, B.1    Peng, S.2    Saigal, B.3    Williams, M.D.4    Johnson, F.M.5
  • 32
    • 0027905014 scopus 로고
    • Altered growth of human colon cancer cell lines disrupted at activated Ki-ras
    • Shirasawa S., Furuse M., Yokoyama N., Sasazuki T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 1993, 260:85-88.
    • (1993) Science , vol.260 , pp. 85-88
    • Shirasawa, S.1    Furuse, M.2    Yokoyama, N.3    Sasazuki, T.4
  • 34
    • 0034795339 scopus 로고    scopus 로고
    • Use of isogenic human cancer cells for high-throughput screening and drug discovery
    • Torrance C.J., Agrawal V., Vogelstein B., Kinzler K.W. Use of isogenic human cancer cells for high-throughput screening and drug discovery. Nat. Biotechnol. 2001, 19:940-945.
    • (2001) Nat. Biotechnol. , vol.19 , pp. 940-945
    • Torrance, C.J.1    Agrawal, V.2    Vogelstein, B.3    Kinzler, K.W.4
  • 35
    • 79956298812 scopus 로고    scopus 로고
    • Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status
    • Van Cutsem E., Köhne C.H., Láng I., Folprecht G., Nowacki M.P., Cascinu S., Shchepotin I., Maurel J., Cunningham D., Tejpar S., et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J.Clin. Oncol. 2011, 29:2011-2019.
    • (2011) J.Clin. Oncol. , vol.29 , pp. 2011-2019
    • Van Cutsem, E.1    Köhne, C.H.2    Láng, I.3    Folprecht, G.4    Nowacki, M.P.5    Cascinu, S.6    Shchepotin, I.7    Maurel, J.8    Cunningham, D.9    Tejpar, S.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.